Home › Funds › Two Sigma Investments › CLOV
Two Sigma Investments position in CLOV
CLOVER HEALTH INVESTMENTS CO · Health Care
Latest position (Q4 2024)504.30K sh
Reported value held$1.59M
Portfolio Weight0.00%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 6.61M | $24.59M | New |
| Q1 2022 | 3.21M | $11.40M | Reduce |
| Q2 2022 | 535.22K | $1.15M | Reduce |
| Q4 2022 | 225.60K | $209.70K | New |
| Q2 2023 | 44.39K | $39.82K | New |
| Q3 2023 | 1.90M | $2.05M | Add |
| Q4 2023 | 3.63M | $3.46M | Add |
| Q1 2024 | 2.53M | $2.01M | Reduce |
| Q2 2024 | 1.40M | $1.72M | Reduce |
| Q3 2024 | 1.64M | $4.62M | Add |
| Q4 2024 | 504.30K | $1.59M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CLOV
- BlackRock Inc 35.11M sh · $183.96M · Q2 2026
- Geode Capital Management 10.85M sh · $56.84M · Q2 2026
- Vanguard Group 23.49M sh · $55.19M · Q4 2025
- Charles Schwab Investment Management 5.52M sh · $28.93M · Q2 2026
- Northern Trust Corp 3.77M sh · $19.77M · Q2 2026
- PNC Financial Services 3.56M sh · $18.67M · Q2 2026
- Renaissance Technologies 2.81M sh · $14.71M · Q2 2026
- Morgan Stanley 2.29M sh · $12.02M · Q2 2026
- D. E. Shaw & Co 1.97M sh · $10.30M · Q2 2026
- Marshall Wace 1.56M sh · $8.19M · Q2 2026
- Invesco Ltd 1.34M sh · $7.00M · Q2 2026
- BNY Mellon 1.21M sh · $6.35M · Q2 2026